Effects of benfluorex metabolites on membrane fluidity and insulin-related processes.
As little work has dealt with the antihyperglycemic property of benfluorex at the hepatocyte level, we studied the effects of its main metabolites, S422 and S1475, on membrane fluidity and on insulin binding, internalization and action in healthy rat hepatocytes. Both metabolites were effective fluidizing agents. Neither one affected insulin binding. Only S422 favored the bound insulin-receptor internalization process. The metabolites produced no change in basal alpha-aminoisobutyric acid uptake. Only S422 promoted the insulin-stimulated alpha-aminoisobutyric acid uptake in a dose-dependent way. Therefore, our study demonstrated that: (i) the effects of S422 on insulin-related processes in isolated hepatocytes were direct, specific and not due to any membrane fluidizing mechanism; (ii) S422 improved hepatocyte response to insulin at a post-binding level. These results in vitro give an additional explanation, at the cellular level, of the benefit of benfluorex treatment for non insulin-dependent diabetes patients.
Orsière
T G
TG
Equipe Protéines Membranaires (GRIPP), URA-CNRS 1924, UFR de Pharmacie, Marseille, France.
Chauvet
M M
MM
Dell'Amico
M H
MH
Bourdeaux
M J
MJ
D000818:Animals; D002478:Cells, Cultured; D005277:Fenfluramine / Q000031:analogs & derivatives* / Q000494:pharmacology; D000960:Hypolipidemic Agents / Q000494:pharmacology*; D007328:Insulin / Q000819:agonists*; D008099:Liver / Q000187:drug effects*; D008297:Male; D008560:Membrane Fluidity / Q000187:drug effects*; D051381:Rats; D017208:Rats, Wistar
D000960:Hypolipidemic Agents; D007328:Insulin; D005277:Fenfluramine; C001584:benfluorex; C095600:1-(3-trifluoromethylphenyl)-2-(2-carboxymethyl)aminopropane